Systemic Loss of FKBPL Uncovers Diabetes-Dependent Pathways of Myocardial and Vascular Injury
Arteriosclerosis, Thrombosis, and Vascular Biology · 2026
DOI: 10.1161/atvbaha.125.323053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Abdelrahim Alqudah und 12 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-Wolfson Institute for Experimental Medicine (A.A., K.S.E., K.M.O., R.M., G.H.L.-C., D.J.G., L.M.), Queen's University Belfast, Northern Irel…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Myocardium, Diabetic Angiopathies, Diabetic Cardiomyopathies. Die Arbeit nennt 71 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Impaired angiogenesis underpins cardiovascular disease, particularly in people with diabetes; however, molecular mechanisms are still poorly understood. This study aims to decipher the role of an emerging antiangiogenic protein, FKBPL (FK506-binding protein–like), on cardiac structure and function, vascular integrity, and inflammatory signaling in in vivo and in vitro models of diabetes. METHODS: In vivo, FKBPL transgenic mice ( fkbpl +/− ) were used to examine the metabolic and cardiovascular function and FKBPL-mediated mechanisms in streptozotocin-induced diabetes. In addition, comprehensive in vitro assessments of endothelial function and mechanisms were performed in normal/high-glucose and high/low-FKBPL conditions. RESULTS: Fkbpl +/− mice show signs of early cardiac remodeling (increased E/A ratio, P =0.047, and cardiomyocytes size, P =0.0018; reduced collagen deposition, P =0.013; col1a1 mRNA reduction, P =0.0028) and aberrant expression of cardiac vascular dysfunction proteins (ICAM-1 [intercellular adhesion molecule 1], P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellcome-Wolfson Institute for Experimental Medicine (A.A., K.S.E., K.M.O., R.M., G.H.L.-C., D.J.G., L.M.), Queen's University Belfast, Northern Ireland, United Kingdom.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan (A.A.).
- School of Life Sciences & Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, New South Wales, Australia (S.Z., M.C., L.M.).
- Heart Research Institute, The University of Sydney, New South Wales, Australia (N.L., M.M.K.).
- Centre for Peripheral Artery Disease, Heart Research Institute, Sydney, New South Wales, Australia (N.L., M.M.K.).
- School of Pharmacy (A.S., T.R.), Queen's University Belfast, Northern Ireland, United Kingdom.
ORCID-Profile: Kevin S Edgar, Ross McNally, Natalie Le, Michael Chhor, Mary M Kavurma, Tracy Robson, Lana McClements
Zitieren
APA
Alqudah, A., Edgar, K. S., O'Neill, K. M., McNally, R., Zhand, S., Le, N., Chhor, M., Short, A., Kavurma, M. M., Lopez-Campos, G. H., Robson, T., Grieve, D. J., & McClements, L. (2026). Systemic Loss of FKBPL Uncovers Diabetes-Dependent Pathways of Myocardial and Vascular Injury. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.323053
Vancouver
Alqudah A, Edgar KS, O'Neill KM, McNally R, Zhand S, Le N, et al. Systemic Loss of FKBPL Uncovers Diabetes-Dependent Pathways of Myocardial and Vascular Injury. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.323053
BibTeX
@article{Alqudah2026,
author = {Alqudah, Abdelrahim and Edgar, Kevin S and O'Neill, Karla M and McNally, Ross and Zhand, Sareh and Le, Natalie and Chhor, Michael and Short, Amy and Kavurma, Mary M and Lopez-Campos, Guillermo H and Robson, Tracy and Grieve, David J and McClements, Lana},
title = {Systemic Loss of FKBPL Uncovers Diabetes-Dependent Pathways of Myocardial and Vascular Injury},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
doi = {10.1161/atvbaha.125.323053}
}
EUVIMED